 Pills and bottles touting that they can boost your sex life may be appealing, but you might want to think twice before putting down your money. While their claims are tempting, they may not be backed by evidence and may even lead to unwanted side effects. “Most supplements for sexual function have not been studied scientifically,” says Luigi Simone, MD, a primary care physician at Scripps Clinic in Encinitas. “They may have a placebo effect, which is not insignificant, but as far as the claims of increasing libido or sexual endurance, those have definitely not been proven.” In fact, using male sexual enhancement supplements to boost your libido or address erectile dysfunction may do more harm than good. Ingredients can trigger side effects, cause allergic reactions and interact with other drugs. Some may even contain potentially dangerous impurities or small amounts of hidden pharmaceutical drugs that can produce dangerous reactions. Talk with your doctor before trying a sexual enhancement supplement. “Don’t be afraid to bring up a sexual health concern,” says Dr. Simone. “We’ve heard them all and are always ready to help you.”
Supplements are products intended to supplement your diet. They are not drugs and can be purchased without prescription at grocery stores, drug stores, natural food stores and other retail outlets. While the FDA has the responsibility to approve the use of any conventional pharmaceutical and to monitor how it is manufactured, the FDA has no such responsibility with regard to supplements. In fact, supplements are not approved by the FDA for the treatment of any medical condition and cannot be marketed that way. By law, dietary supplements must contain at least one vitamin, mineral, amino acid, enzyme, or other substance used by the body. But the rest of the ingredients may include drugs that are untested for safety or effectiveness. That means unscrupulous companies and manufacturers can sell any products they like without regard to veracity or science. The supplements won’t be pulled from the shelves until and unless the FDA proves they’re unsafe. The FDA can take action if it finds any supplement to be unsafe once it reaches the market and can remove the product from the marketplace. You can check online at the National Institutes of Health for more information about supplements. Your doctor should also be able to answer your questions.
Sexual enhancement supplements are supplements made from a natural substance. They may contain nutrients called amino acids, vitamins and minerals or herbs like palmetto, yohimbe or maca. Most products are tablets, caplets or tablets. Sexual enhancements supplements have become more prevalent as the population ages and more people are diagnosed with disorders that require medication that may lead to sexual problems as side effects. In addition, increased consumption of alcohol and smoking have increased the prevalence of sexual health problems, such as erectile dysfunction.
Remember, it’s always best to talk to your doctor about any sexual health problem that you may be experiencing. “Do not self-diagnose and think that supplements are going to cure or prevent a problem from occurring,” Dr. Simone says. “Your doctor can discuss any sexual concern you may have and determine if there is an underlying cause for your symptoms that needs to be treated. If you have sexual side effects from medication you can ask your doctor if you can change your medication. Your doctor can also help you determine which supplements, if any, might help you.” Lifestyle changes — such as losing weight and getting more exercise or smoking cessation — can help boost your sexual health without medication. Weight loss, decreased stress and a healthy lifestyle have all been shown to increase testosterone levels in men, according to Dr. Simone.
1. World Health Organization. Definitions of SSFFC Medical Products. Accessed January 23, 2016. Available online: http://www.who.int/medicines/regulation/ssffc/definitions/en/ 2. Hellstrom WJ. The growing concerns regarding counterfeit medications. J Sex Med 2011;8:1-3. 10.1111/j.1743-6109.2010.02135.x [PubMed] [CrossRef] [Google Scholar] 3. World Health Organization. Counterfeit medicines. Available online: https://www.gphf.org/images/downloads/library/who_factsheet275.pdf 4. Pharmaceutical Security Institute. Counterfeit situation. Incident trend. Accessed January 23, 2016. Available online: http://www.psi-inc.org/incidentTrends.cfm 5. The Economist. Poison pills. Accessed February 26, 2016. Available online: http://www.economist.com/node/16943895 6. Taverriti-Fortier C, Pape E, Scala-Bertola J, et al. Counterfeit and Falsified Drugs: an Overview. Therapie 2015;70:455-64. 10.2515/therapie/2015031 [PubMed] [CrossRef] [Google Scholar] 7. Jack A. Counterfeit medicines. Bitter pills. BMJ 2007;335:1120-1. 10.1136/bmj.39412.431655.AD [PMC free article] [PubMed] [CrossRef] [Google Scholar] 8. Jackson G, Arver S, Banks I, et al. Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks. Int J Clin Pract 2010;64:497-504. 10.1111/j.1742-1241.2009.02328.x [PMC free article] [PubMed] [CrossRef] [Google Scholar] 9. Venhuis BJ, de Voogt P, Emke E, et al. Success of rogue online pharmacies: sewage study of sildenafil in the Netherlands. BMJ 2014;349:g4317. 10.1136/bmj.g4317 [PubMed] [CrossRef] [Google Scholar] 10. Prins J, Blanker MH, Bohnen AM, et al. Prevalence of erectile dysfunction: a systematic review of population-based studies. Int J Impot Res 2002;14:422-32. 10.1038/sj.ijir.3900905 [PubMed] [CrossRef] [Google Scholar] 11. Bingham J. Drug dealers 'switching from cocaine to fake Viagra'. The Telegraph 2009. Accessed January 24, 2016. Available online: http://www.telegraph.co.uk/news/uknews/law-and-order/4925836/Drug-dealers-switching-from-cocaine-to-fake-Viagra.html 12. Dorsey PJ, Hellstrom WJ. The Illicit Sale of Medications for the Treatment of Erectile Dysfunction. Accessed January 24, 2016. Available online: http://www.medscape.com/viewarticle/566897_3 13. Shaeer O. The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers. J Sex Med 2013;10:532-40. 10.1111/j.1743-6109.2012.02972.x [PubMed] [CrossRef] [Google Scholar] 14. Schnetzler G, Banks I, Kirby M, et al. Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors. J Sex Med 2010;7:1237-46. 10.1111/j.1743-6109.2009.01674.x [PubMed] [CrossRef] [Google Scholar] 15. Travison TG, Hall SA, Fisher WA, et al. Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys. J Sex Med 2011;8:3051-7. 10.1111/j.1743-6109.2011.02423.x [PMC free article] [PubMed] [CrossRef] [Google Scholar] 16. Lowe G, Costabile R. Phosphodiesterase type 5 inhibitor abuse: a critical review. Curr Drug Abuse Rev 2011;4:87-94. 10.2174/1874473711104020087 [PubMed] [CrossRef] [Google Scholar] 17. Campbell N, Clark JP, Stecher VJ, et al. Internet-ordered viagra (sildenafil citrate) is rarely genuine. J Sex Med 2012;9:2943-51. 10.1111/j.1743-6109.2012.02877.x [PubMed] [CrossRef] [Google Scholar] 18. Dorsey P, Keel C, Klavens M, et al. Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction. Expert Opin Pharmacother 2010;11:1109-22. 10.1517/14656561003698131 [PubMed] [CrossRef] [Google Scholar] 19. Ignarro LJ. Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol Toxicol 1990;67:1-7. 10.1111/j.1600-0773.1990.tb00772.x [PubMed] [CrossRef] [Google Scholar] 20. Rajfer J, Aronson WJ, Bush PA, et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992;326:90-4. 10.1056/NEJM199201093260203 [PubMed] [CrossRef] [Google Scholar] 21. Gur S, Kadowitz PJ, Gokce A, et al. Update on drug interactions with phosphodiesterase-5 inhibitors prescribed as first-line therapy for patients with erectile dysfunction or pulmonary hypertension. Curr Drug Metab 2013;14:265-9. [PubMed] [Google Scholar] 22. Taylor J, Baldo OB, Storey A, et al. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors. BJU Int 2009;103:1392-5. 10.1111/j.1464-410X.2008.08328.x [PubMed] [CrossRef] [Google Scholar] 23. Kubin M, Wagner G, Fugl-Meyer AR. Epidemiology of erectile dysfunction. Int J Impot Res 2003;15:63-71. 10.1038/sj.ijir.3900949 [PubMed] [CrossRef] [Google Scholar] 24. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005;96:85M-93M. 10.1016/j.amjcard.2005.12.018 [PubMed] [CrossRef] [Google Scholar] 25. Miner M, Nehra A, Jackson G, et al. All men with vasculogenic erectile dysfunction require a cardiovascular workup. Am J Med 2014;127:174-82. 10.1016/j.amjmed.2013.10.013 [PubMed] [CrossRef] [Google Scholar] 26. Kirby MG, Schnetzler G, Zou KH, et al. Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study. Int J Clin Pract 2011;65:797-806. 10.1111/j.1742-1241.2011.02693.x [PubMed] [CrossRef] [Google Scholar] 27. Stecher VJ, Jackson G, Banks I, et al. Analysis of Pharmaceuticals Seized by Authorities for Suspicion of Being Counterfeit Viagra® (Sildenafil Citrate). Lyon, France: European Society for Sexual Medicine, 2009. [Google Scholar] 28. Gaudiano MC, Manna L, Rodomonte AL, et al. A survey on illegal and counterfeit medicines for the treatment of erectile dysfunctions in Italy. J Sex Med 2012;9:2130-7. 10.1111/j.1743-6109.2012.02770.x [PubMed] [CrossRef] [Google Scholar] 29. Pullirsch D, Bellemare J, Hackl A, et al. Microbiological contamination in counterfeit and unapproved drugs. BMC Pharmacol Toxicol 2014;15:34. 10.1186/2050-6511-15-34 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 30. Taher A, Setiawati A. VICTORY project: a study of counterfeit PDE5 inhibitor (sildenafil) in Indonesia. Acta Med Indones 2013;45:290-4. [PubMed] [Google Scholar] 31. Kao SL, Chan CL, Tan B, et al. An unusual outbreak of hypoglycemia. N Engl J Med 2009;360:734-6. 10.1056/NEJMc0807678 [PubMed] [CrossRef] [Google Scholar] 32. Campbell N, Clark JP, Stecher VJ, et al. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. J Sex Med 2013;10:1842-9. 10.1111/jsm.12172 [PubMed] [CrossRef] [Google Scholar] 33. FDA Announces New Supplement Recall. Accessed March 9th, 2016. Available online: http://community.auanet.org/blogs/policy-brief/2016/01/19/fda-announces-new-supplement-recall?utm_term=&utm_content=buffer22d4d&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer 34. World Health Organization. Health Impact Assessment. Available online: http://www.who.int/hia/en/ 35. Paxton M. Current challenges with supply-chain integrity and the threat to the quality of marketed drugs. Clin Pharmacol Ther 2011;89:316-9. 10.1038/clpt.2010.288 [PubMed] [CrossRef] [Google Scholar] 36. U.S. Food & Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Availble online: http://www.fda.gov/medwatch 37. U.S. Food & Drug Administration. Counterfeit Medicine. Availble online: http://www.fda.gov /Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/CounterfeitMedicine/ Page 2Common medications and dietary supplements with interactions with phosphodiesterase-5 inhibitors (PDE-5i)
|
What are the long term effects of male enhancement pills?
Postagens relacionadas
direito autoral © 2024 estudarpara Inc.
